介入治疗肝海绵状血管瘤平阳霉素碘油乳剂用量的探讨  

The Dose of Pingyangmycin Lipiodol Emulsion in the Intra-arterial Embolization for Hepatic Cavernous Hemangioma

作　　者：靳海英[1] 霍守义[2] 张和平[1] 贺祥[1] 张杰[1] 任学群[1] 李长波[1] 索智敏[1] 

机构地区：[1]河南大学淮河医院影像科,河南开封475000 [2]河南大学东京医院影像科

出　　处：《实用放射学杂志》2006年第10期1257-1259,1269,共4页Journal of Practical Radiology

基　　金：河南大学2001年自然科学基金(编号:XK-02126)

摘　　要：目的探讨介入治疗肝海绵状血管瘤的栓塞剂用量。方法超选择性肝动脉插管平阳霉素碘化油乳剂(PLE)栓塞治疗肝海绵状血管瘤40例,根据栓后瘤周有无碘油进入分为2组。对比观察2组药物用量、疗效、并发症。结果2组有效率无显著差异,药物用量、持续性疼痛发生率碘油进入门静脉组均高于对照组。结论CHL栓塞治疗中,栓塞剂用量应以个体化原则,以不出现瘤周门静脉碘油进入为宜。Objective To discuss the dose of pingyangmycin lipiodol emulsion （ PLE ） in the intra - arterial embolization for cavernous hemangioma of liver（CHL） . Methods 40 eases of CHL were treated by super - selective hepatic artery embolization with PLE and divided into two groups according to whether lipiodol flowing into portal vein （ LFPV ） after hepatic artery embolization. The dosage of PLE, therapeutic effect and complications were comparatively analysed between two groups. Results There was no significance between two groups in effective rate （ P 〉 0.05 ）. The dosage and durative ache in group of LFPV was higher than that in another （ P 〈 0.05 ）. Conclusion The dosage of PLE should base on individuality and no lipiodol flowing into portal vein after hepatic artery embolization is better.

关 键 词：肝脏 血管瘤 栓塞 治疗性 碘油 平阳霉素 

分 类 号：R734.2[医药卫生—肿瘤] R815[医药卫生—临床医学]